Literature DB >> 24782079

Trends in prescription of opioids from 2003-2009 in persons with knee osteoarthritis.

Elizabeth A Wright1, Jeffrey N Katz, Stanley Abrams, Daniel H Solomon, Elena Losina.   

Abstract

OBJECTIVE: Osteoarthritis (OA) of the knee is a painful condition affecting ∼13% of persons ages >65 years. We sought to examine whether the use of opioids in older persons with OA has increased over the past decade and what patient characteristics may correlate with their use.
METHODS: We assembled national cohorts of individuals with knee OA using data from the 2003, 2006, and 2009 waves of the Medicare Current Beneficiary Survey. The survey data contained information on demographics, health status, and prescribed medications linked to Medicare claims. We used multivariate logistic regression to establish whether opioid use changed over time and to identify factors associated with greater opioid use. The outcome was defined as receiving ≥1 opioid prescription in the study year.
RESULTS: The mean age and sex were similar across years (77 years and 69% women, respectively). There was a significant increase in opioid prescribing between 2003 and 2009, with 31% of patients receiving opioids in 2003, 39% in 2006, and 40% in 2009 (odds ratio [OR] 1.5, 95% confidence interval [95% CI] 1.1-2.0 for 2006 and 2009 compared with 2003). Independent correlates of opioid use across time periods included female sex (OR 1.5, 95% CI 1.2-2.0), functional limitation (OR 2.1, 95% CI 1.6-2.7), poor self-reported health status (OR 1.6, 95% CI 1.2-2.0), chronic obstructive pulmonary disease (OR 1.4, 95% CI 1.0-1.8), and musculoskeletal disease besides OA (OR 1.9, 95% CI 1.2-2.8).
CONCLUSION: As the prevalence and incidence of knee OA continues to increase, the public health impact of greater opioid use should be monitored carefully.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24782079      PMCID: PMC4177407          DOI: 10.1002/acr.22360

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  40 in total

1.  Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors.

Authors:  Jennifer Couzin
Journal:  Science       Date:  2004-10-15       Impact factor: 47.728

Review 2.  Global safety of coxibs and NSAIDs.

Authors:  Kevin Pham; Raimund Hirschberg
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

3.  Opioids for chronic pain of non-malignant origin--caring or crippling.

Authors:  R G Large; S A Schug
Journal:  Health Care Anal       Date:  1995-02

Review 4.  Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors:  D Mukherjee; S E Nissen; E J Topol
Journal:  JAMA       Date:  2001 Aug 22-29       Impact factor: 56.272

5.  EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).

Authors:  A Pendleton; N Arden; M Dougados; M Doherty; B Bannwarth; J W Bijlsma; F Cluzeau; C Cooper; P A Dieppe; K P Günther; H J Hauselmann; G Herrero-Beaumont; P M Kaklamanis; B Leeb; M Lequesne; S Lohmander; B Mazieres; E M Mola; K Pavelka; U Serni; B Swoboda; A A Verbruggen; G Weseloh; I Zimmermann-Gorska
Journal:  Ann Rheum Dis       Date:  2000-12       Impact factor: 19.103

6.  Older adults living with osteoarthritis: examining the relationship of age and gender to medicine use.

Authors:  Judith E Fisher; Peri J Ballantyne; Gillian A Hawker
Journal:  Can J Aging       Date:  2012-07-31

7.  Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial.

Authors:  Stephen P Messier; Richard F Loeser; Gary D Miller; Timothy M Morgan; W Jack Rejeski; Mary Ann Sevick; Walter H Ettinger; Marco Pahor; Jeff D Williamson
Journal:  Arthritis Rheum       Date:  2004-05

8.  Economic study on the impact of side effects in patients taking oxycodone controlled-release for noncancer pain.

Authors:  Kathryn P Anastassopoulos; Wing Chow; Crisanta I Tapia; Rebecca Baik; Stacey J Ackerman; David Biondi; Myoung S Kim
Journal:  J Manag Care Pharm       Date:  2012-10

9.  Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial.

Authors:  Stephen P Messier; Shannon L Mihalko; Claudine Legault; Gary D Miller; Barbara J Nicklas; Paul DeVita; Daniel P Beavers; David J Hunter; Mary F Lyles; Felix Eckstein; Jeff D Williamson; J Jeffery Carr; Ali Guermazi; Richard F Loeser
Journal:  JAMA       Date:  2013-09-25       Impact factor: 56.272

10.  Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010.

Authors:  Kristen Kenan; Karin Mack; Leonard Paulozzi
Journal:  Open Med       Date:  2012-04-10
View more
  45 in total

1.  Impact of Preoperative Opioid Use on Total Knee Arthroplasty Outcomes.

Authors:  Savannah R Smith; Jennifer Bido; Jamie E Collins; Heidi Yang; Jeffrey N Katz; Elena Losina
Journal:  J Bone Joint Surg Am       Date:  2017-05-17       Impact factor: 5.284

2.  Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids.

Authors:  Mohamed Noureldin; Peter D R Higgins; Shail M Govani; Shirley Cohen-Mekelburg; Brooke C Kenney; Ryan W Stidham; Jennifer F Waljee; Akbar K Waljee
Journal:  Aliment Pharmacol Ther       Date:  2018-11-14       Impact factor: 8.171

3.  Association of Tramadol Use With Risk of Hip Fracture.

Authors:  Jie Wei; Nancy E Lane; Marcy B Bolster; Maureen Dubreuil; Chao Zeng; Devyani Misra; Na Lu; Hyon K Choi; Guanghua Lei; Yuqing Zhang
Journal:  J Bone Miner Res       Date:  2020-02-05       Impact factor: 6.741

4.  Preoperative Opioid Misuse is Associated With Increased Morbidity and Mortality After Elective Orthopaedic Surgery.

Authors:  Mariano E Menendez; David Ring; Brian T Bateman
Journal:  Clin Orthop Relat Res       Date:  2015-02-19       Impact factor: 4.176

5.  Evaluation of opioid use among patients with back disorders and arthritis.

Authors:  Corey J Hayes; Nalin Payakachat; Chenghui Li
Journal:  Qual Life Res       Date:  2018-07-23       Impact factor: 4.147

6.  Patterns and predictors of persistent opioid use following hip or knee arthroplasty.

Authors:  S C Kim; N Choudhry; J M Franklin; K Bykov; M Eikermann; J Lii; M A Fischer; B T Bateman
Journal:  Osteoarthritis Cartilage       Date:  2017-04-19       Impact factor: 6.576

7.  Association of Geography and Access to Health Care Providers With Long-Term Prescription Opioid Use in Medicare Patients With Severe Osteoarthritis: A Cohort Study.

Authors:  Rishi J Desai; Yinzhu Jin; Patricia D Franklin; Yvonne C Lee; Brian T Bateman; Joyce Lii; Daniel H Solomon; Jeffrey N Katz; Seoyoung C Kim
Journal:  Arthritis Rheumatol       Date:  2019-04-02       Impact factor: 10.995

Review 8.  Osteoarthritis year in review 2015: clinical.

Authors:  L Sharma
Journal:  Osteoarthritis Cartilage       Date:  2016-01       Impact factor: 6.576

9.  Effects of Pain, Insomnia, and Depression on Psychoactive Medication Supply in Older Adults With Osteoarthritis.

Authors:  Minhui Liu; Susan M McCurry; Basia Belza; Diana T Buchanan; Adrian Dobra; Michael Von Korff; Michael V Vitiello
Journal:  Med Care       Date:  2018-12       Impact factor: 2.983

10.  Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.

Authors:  J N Katz; S R Smith; J E Collins; D H Solomon; J M Jordan; D J Hunter; L G Suter; E Yelin; A D Paltiel; E Losina
Journal:  Osteoarthritis Cartilage       Date:  2015-10-23       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.